Following the association between hypocretin‐1 and HIF‐1α60, simply providing cellular‐level validation, we further found that HIF‐1α may be negatively regulated by hypocretin‐1, disrupting the glycolytic pathway and becoming a potential target for the treatment of cognitive dysfunction in depression. The gene discussed is HIF1A; the disease is major depressive disorder.